Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis Balakumaran A; Robey PG; Fedarko N; Landgren OExpert Rev Mol Diagn 2010[May]; 10 (4): 465-80Multiple myeloma (MM) is the second most common hematological malignancy, with an overall survival of 4-6 years. It is always preceded by a premalignant stage called monoclonal gammopathy of unknown significance (MGUS). Importantly, at this time we lack reliable predictors to determine who will progress from MGUS to MM, and who will remain stable. The bone marrow microenvironment plays a key role in myelomagenesis (growth, survival and migration of malignant plasma cells). In the present review, we summarize and discuss our current understanding of the bone marrow microenvironment and its compartments in relation to myelomagenesis. Although it remains to be proven, we believe that an improved characterization of the cellular constituents, the extracellular matrix components and the soluble factors of the bone marrow could open up novel avenues to better understand underlying mechanisms of the transformation from MGUS to MM. Ultimately, this will lead to the development of early treatment of high-risk precursor disease aimed to delay/prevent MM.|*Bone Marrow/metabolism/pathology[MESH]|*Environment[MESH]|*Multiple Myeloma/diagnosis/metabolism/pathology[MESH]|Biomarkers/metabolism[MESH]|Bone Marrow Cells/metabolism[MESH]|Disease Progression[MESH]|Early Diagnosis[MESH]|Humans[MESH]|Monoclonal Gammopathy of Undetermined Significance/physiopathology[MESH]|Prognosis[MESH]|Risk Factors[MESH] |
